Clinical trial
Impact on Duration of Antibiotic Therapy of Rapid Molecular Diagnostic Method for Rapid Analysis of Susceptibility of Peritoneal Samples in Postoperative Peritonitis in ICU Patients
NCT04925388 is registered in ClinicalTrials.gov with Assistance Publique - Hôpitaux de Paris as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact on Duration of Antibiotic Therapy of Rapid Molecular Diagnostic Method for Rapid Analysis of Susceptibility of Peritoneal Samples in Postoperative Peritonitis in ICU Patients
- Lead sponsor
- Assistance Publique - Hôpitaux de Paris
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- December 30, 2022
- Completion date
- March 5, 2024
- Enrollment
- 16 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.
postoperative peritonitis